COMMUNIQUÉS West-GlobeNewswire
-
Celldex Announces Planned Transition of Chief Financial Officer
15/07/2026 -
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
15/07/2026 -
Medicare Covers Online Therapy in New York: MMHC's Medicare-Enrolled Therapists Now Accepting New Patients Statewide at $0 to $27 Per Session
15/07/2026 -
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
15/07/2026 -
ARCPOINT ANTICIPATES DELAY IN FILING ANNUAL FINANCIAL STATEMENTS
16/07/2026 -
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
15/07/2026 -
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
15/07/2026 -
Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy
15/07/2026 -
Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease
15/07/2026 -
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
15/07/2026 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2026
15/07/2026 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine xx - 2025
15/07/2026 -
Hyperion DeFi Enters Agreement with Skew Technologies to Launch HIP-3 Perpetual Futures Market and Listing Service
15/07/2026 -
RadioMedix Appoints Brian A. Markison to Board of Directors
15/07/2026 -
At 68, Nutrition World Founder Edward Jones Returns to the Bodybuilding Stage and Challenges Assumptions About Aging
15/07/2026 -
Rainwater Drake Dental Announces Name Change From Hawkins Rainwater Dental Group
15/07/2026 -
Retrieve Medical Partners With Clear to Enhance Identity Verification For The Retrieve Medical Passport
15/07/2026 -
NewcelX Granted Patent in Brazil for NCEL-101 in Type 1 Diabetes, Expanding Global IP Portfolio
15/07/2026 -
Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)
15/07/2026
Pages